This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Otolaryngology/ Head & Neck Surgery  • Pediatric Otolaryngology  • Pediatrics, Other  • Quality of Care, Other  • Alert me on articles by topic

Rita Mangione-Smith, MD, MPH; Marc N. Elliott, PhD; Lok Wong, MS; Laurie McDonald, MS; Joachim Roski, PhD

Arch Pediatr Adolesc Med. 2005;159:491-497.

Background  There is a high degree of professional consensus that children diagnosed with pharyngitis should only receive antibiotics if they have a positive test for group A streptococcus (GAS).

Objectives  To develop and test the validity of a quality of care performance measure that examines GAS testing rates in children diagnosed with pharyngitis and prescribed an antibiotic.

Design  The measure developed examines the annual rate of GAS testing in children aged 2 to 18 years with an episode of pharyngitis who were prescribed antibiotics. The measure was tested for feasibility of implementation and validity in 5 health plans in the United States. Health plan administrative data were used to identify episodes of pharyngitis using International Classification of Diseases, Ninth Revision (ICD-9) codes 462, 463, and 034.0. Pharmacy data (National Drug Codes) were used to determine if antibiotics were prescribed for the pharyngitis episode. Laboratory claims data (Current Procedural Terminology codes) were used to determine whether a GAS test was performed. Rates of GAS testing in children with pharyngitis who received antibiotics were calculated for each health plan. Medical record abstractions were performed on a random sample (n = 465) of cases to assess percent agreement with laboratory claims data for GAS testing. Sensitivity of the administrative data for accurately identifying when GAS tests were performed was also assessed.

Results  Of the 120 158 children aged 2 to 18 years who had at least 1 episode of pharyngitis during the measurement year, 51 172 (43%) received antibiotics. Group A streptococcal testing rates for patients who were prescribed antibiotics varied widely among the participating health plans (59%-83% of cases; P<.05). Percent agreement between administrative and medical records data for GAS tests was 86%. The sensitivity of the administrative data for accurately identifying when GAS tests were performed was 85%.

Conclusions  This quality measure is feasible to implement at the health plan level and validly assesses GAS testing rates using administrative data. The participating health plans are not performing GAS tests as indicated by current expert practice guidelines in a substantial proportion of cases. Improvements in adhering to these guidelines are warranted given the current levels of antibiotic overuse and antibiotic resistance nationally.

Author Affiliations: Department of Pediatrics, University of California, Los Angeles (Dr Mangione-Smith); RAND, Health Program, Santa Monica, Calif (Drs Elliott and McDonald); National Committee for Quality Assurance, Washington, DC (Ms Wong and Dr Roski).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quality of Care in the Retail Health Care Setting Using National Clinical Guidelines for Acute Pharyngitis
Woodburn et al.
American Journal of Medical Quality 2007;22:457-462.
ABSTRACT  

Clinicians' management of children and adolescents with acute pharyngitis.
Park et al.
Pediatrics 2006;117:1871-1878.
ABSTRACT | FULL TEXT  

Antibiotic Treatment of Children With Sore Throat
Linder et al.
JAMA 2005;294:2315-2322.
ABSTRACT | FULL TEXT